Clinical Trial Update: Piperacillin-Tazobactam Continuous Versus Intermittent Infusion for Pseudomonas Aeruginosa [Phase 3]

View source ↗

Summary

This document provides an update on a Phase 3 clinical trial comparing continuous versus intermittent infusion of Zosyn (piperacillin-tazobactam) for Pseudomona…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pseudomonas Aeruginosa Infection

Drugs mentioned

• Zosyn (Piperacillin/tazobactam)

Snippet

Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | Conditions: Pseudomonas Aeruginosa Infection | Phase 3 | Status: COMPLETED